osteoporosis
OSTEOPOROSIS
Osteoporosis is the progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history, of fracture, advanced age, comorbidities, impaired vision) that are present, the greater the risk of fracture.
Drug Information

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Correction of combined vit D & Ca deficiency in the elderly. Adjunct to treatment of osteoporosis in patie...

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clin...

Indication: Postmenopausal osteoporosis. Reduce risk of vertebral & hip fractures.

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Calcium with Vitamin D Plus YSP
calcium carbonate + vitamin D

Indication: Dietary supplement.

Calcium with Vitamin D YSP
calcium + vitamin D3

Indication: Prevention of Ca deficiency.

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Podcast: Dr Shamir Mehta briefly discusses the clinical impact of findings from the COMPLETE trial
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.
5 days ago
Podcast: Prof Derek Chew explains the importance of a 1-hour troponin T protocol in suspected ACS as discussed in the RAPID-TnT trial
6 days ago
Sodium-glucose transport protein 2 (SGLT2) inhibitors exert a putative epigenetic regulation of the protecting cardiovascular effect, reports a study, adding that dapagliflozin may protect the kidneys by preserving renal vasodilating capacity.